---
document_datetime: 2023-09-21 22:15:05
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ivabradine-zentiva-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: ivabradine-zentiva-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.4386581
conversion_datetime: 2025-12-28 03:30:29.025734
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Ivabradine Zentiva

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                       | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0015              | B.II.a.2.b - Change in the shape or dimensions of the pharmaceutical form - Gastro-resistant, modified or prolonged release pharmaceutical forms and scored tablets intended to be divided into equal doses | 13/07/2023                          |                                             | SmPC and PL                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| II/0014   | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                  | 20/04/2023   | n/a        |                                  |                                                                                                                                                                                                                                                                                  |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0013    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 19/08/2022   |            | PL                               |                                                                                                                                                                                                                                                                                  |
| IB/0012   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                         | 31/05/2022   | n/a        |                                  |                                                                                                                                                                                                                                                                                  |
| IB/0011   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 07/02/2022   | 24/03/2023 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                  |
| IB/0010   | B.II.e.1.b.1 - Change in immediate packaging of the finished product - Change in type/addition of a new container - Solid, semi-solid and non-sterile liquid pharmaceutical forms                                                                            | 07/01/2022   | n/a        |                                  |                                                                                                                                                                                                                                                                                  |
| IA/0009   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                | 13/12/2021   | n/a        |                                  |                                                                                                                                                                                                                                                                                  |
| R/0008    | Renewal of the marketing authorisation.                                                                                                                                                                                                                      | 22/07/2021   | 29/09/2021 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Ivabradine Zentiva in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |

<div style=\"page-break-after: always\"></div>

| IB/0007   | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 12/11/2020   | n/a        |                 |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|
| IB/0006/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging | 06/02/2020   | 29/01/2021 | Annex II and PL |

<div style=\"page-break-after: always\"></div>

| B.II.b.1.e - Replacement manufacturing site for the manufacturing operation(s) release, batch control, primary packaging, for non-sterile B.II.b.2.c.2 - Change to arrangements and quality Including batch control/testing B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.c.2.a - Change in test - Minor changes to an approved B.II.c.2.a - Change in test - Minor changes to an approved B.II.c.2.a - Change in test - Minor changes to an approved B.II.c.2.a - Change in test - Minor changes to an approved B.II.c.2.d - Change in test - Other changes to a test replacement or addition) B.II.c.2.d - Change in test - Other changes to a test replacement or addition) B.II.c.2.d - Change in test - Other changes to a test replacement or addition) B.II.d.2.a - Change in test product - Minor changes procedure   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           | to a test procedure (including replacement or addition) B.II.d.2.e - Change in test procedure for the finished product - Update of the test procedure to comply with the updated general monograph in the Ph. Eur. B.II.e.2.z - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Other variation B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products   |            |     | product - Other changes   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------------|
| IB/0005/G | This was an application for a group of variations. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor approved test procedure                                                                                                                                                                               | 07/05/2019 | n/a | changes to an             |
| IG/1029   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                           | 18/12/2018 | n/a |                           |
| IA/0003/G | This was an application for a group of variations. B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient                                                                                                                                                                                                                                                                             | 15/05/2018 | n/a |                           |

<div style=\"page-break-after: always\"></div>

|         | - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure   |            |            |      |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|
| IB/0002 | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                                                                                                                   | 28/09/2017 | n/a        |      |
| IB/0001 | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                      | 21/08/2017 | 13/08/2018 | SmPC |